Medicine & Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy; Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
Diagnostic and Interventional Radiology Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Semin Arthritis Rheum. 2024 Oct;68:152525. doi: 10.1016/j.semarthrit.2024.152525. Epub 2024 Aug 5.
to summarize the evidence on the efficacy of minimally invasive interventional procedures such as radiofrequency ablation (RFA) and transcatheter arterial embolization (TAE) in patients with osteoarthritis or inflammatory arthritis.
a literature search was conducted in PubMed and Web of Science databases. Both randomized controlled trials (RCTs) and non-randomized studies of interventions (NRSI) were included. The results were organized according to the treated anatomical site: knee, hip, foot and ankle, shoulder, hand and wrist, sacroiliac joints. Data about treatment efficacy were extracted. The main outcome was change in pain intensity using the 0-10 visual analog scale (VAS) from baseline to 1 month. Additional timepoints at 3, 6 and 12 months were assessed. Change in functional status was evaluated. Pooled estimates were calculated as the mean difference (MD) and 95 % confidence interval relative to baseline. The meta-analyses of RCTs and NRSI were conducted separately.
of the 4599 retrieved articles, 164 were included in the review and, considering all the established timepoints, 111 (38 RCTs and 73 NRSI) were selected for the meta-analysis. Only one article described patients with inflammatory arthritis. In the meta-analysis of RCTs, one month after the procedure, MD in VAS was -3.98 (-4.41 to -3.55; k = 21) for knee RFA, and -3.18 (-3.96 to -2.39; k = 8) for sacroiliac joints RFA. In the meta-analysis of NRSI, MD in VAS was -4.12 (-4.63 to -3.61; k = 23) for knee RFA, -3.84 (-4.77 to -2.92; k = 7) for knee TAE, -4.34 (-4.96 to -3.71; k = 2) for hip RFA, -3.83 (-4.52 to -3.15; k = 3) for shoulder RFA and -4.93 (-5.58 to -4.28; k = 14) for sacroiliac joints RFA. Significant decrease in pain intensity was found also at 3, 6 and 12 months. Additionally, functional status improved at all the assessed timepoints.
minimally invasive interventional procedures can improve pain and functional status of patients affected by OA or chronic sacroiliac pain of degenerative origin. Further research is warranted in the field of inflammatory rheumatic diseases.
总结经皮微创介入治疗(如射频消融术[RFA]和经导管动脉栓塞术[TAE])在骨关节炎或炎症性关节炎患者中的疗效证据。
在 PubMed 和 Web of Science 数据库中进行文献检索。纳入随机对照试验(RCT)和干预性非随机研究(NRSI)。根据治疗的解剖部位对结果进行组织:膝关节、髋关节、足踝、肩关节、手和腕关节、骶髂关节。提取关于治疗效果的数据。主要结局为从基线到 1 个月时使用 0-10 视觉模拟量表(VAS)评估疼痛强度的变化。评估了 3、6 和 12 个月的其他时间点。评估了功能状态的变化。相对于基线计算了汇总估计值,即平均差异(MD)和 95%置信区间。分别对 RCT 和 NRSI 的荟萃分析进行了分析。
在检索到的 4599 篇文章中,有 164 篇被纳入综述,在考虑所有已建立的时间点的情况下,有 111 篇(38 篇 RCT 和 73 篇 NRSI)被纳入荟萃分析。只有一篇文章描述了炎症性关节炎患者。在 RCT 的荟萃分析中,膝关节 RFA 术后 1 个月时 VAS 的 MD 为-3.98(-4.41 至-3.55;k=21),骶髂关节 RFA 为-3.18(-3.96 至-2.39;k=8)。在 NRSI 的荟萃分析中,膝关节 RFA 术后 1 个月时 VAS 的 MD 为-4.12(-4.63 至-3.61;k=23),膝关节 TAE 为-3.84(-4.77 至-2.92;k=7),髋关节 RFA 为-4.34(-4.96 至-3.71;k=2),肩关节 RFA 为-3.83(-4.52 至-3.15;k=3),骶髂关节 RFA 为-4.93(-5.58 至-4.28;k=14)。在所有评估的时间点,疼痛强度均显著降低。此外,在所有评估的时间点,功能状态都有所改善。
经皮微创介入治疗可改善 OA 或退行性起源的慢性骶髂关节痛患者的疼痛和功能状态。炎症性风湿性疾病领域需要进一步研究。